“ipo” Archives

in
Entry Author Date Location
East Coast Biotech Roundup: Editas, Hep C, Akashi, Tarveda & More 01/29/16 Boston
As Markets and Controversies Swirl, Editas Aims For $100M CRISPR IPO 01/25/16 Boston
From California to New York, Fintech Finds Loans for Almost Anyone 01/20/16 National
Eyeing First Trials, Syros Brings in $40M and More Crossovers 01/13/16 Boston
East Coast Bio Roundup: NY Startups, Editas, Bonney, C4 & (Much) More 01/08/16 Boston
Flash Sale: Web Retailer Gilt Groupe Sells to Hudson Bay for $250M 01/07/16 New York
Ever Fond of Options, Atlas Finds Potential Buyers For Rodin, Quartet 01/06/16 Boston
Eight Things You Might Not Have Known Until Editas Filed Its S-1 01/04/16 Boston
Scholar Rock Rolls Up $36M To Move Muscle Drug To Clinical Trials 01/04/16 Boston
Texas 2015: Bio IPOs, Mark Cuban, Dell, & Startups in Wine, Aviation 12/31/15 Texas
Innovation vs. Healthcare Spending: Biotech’s Biggest Looming Challenge 12/28/15 National
Acacia Aims to Go Public as Disappointing Year For Tech IPOs Closes 12/22/15 Boston
Months After Postponed IPO, Gelesis Nabs $31.5M And a New Investor 12/18/15 Boston
London Notebook: Conversations Inside The Biomedical Golden Triangle 12/15/15 National
East Coast Biotech Roundup: ASH, Kallyope, SQZ, Kyras & More 12/11/15 Boston
With Drugs in Clinic, Constellation Nabs $55M For IPO Push 12/09/15 Boston
West Coast Bio Roundup: Gene Edit Talk, Not Poor ORIC, BioMarin Sags 12/04/15 San Francisco
Austin Fintech Company Q2 Holdings Acquires Iowa Software Firm 12/01/15 Texas
Mimecast, Square IPOs Disappoint in Challenging Environment for Tech 11/18/15 Boston
Big Deals in Texas (ZS Pharma, HomeAway, Gravitant) & Other News 11/09/15 Texas
West Coast Biotech Roundup: KaloBios, Atreca, Acadia, Twist & More 11/06/15 San Francisco
AstraZeneca Buys Texas-Born Biotech ZS Pharma in $2.7B Deal 11/06/15 Texas
Kura Oncology Drops Price of IPO Shares From $16 to $8 11/04/15 San Diego
Expedia Buys Austin’s HomeAway for $3.9B 11/04/15 Texas
Parallel Paths of Constant Contact, Endurance Converge in $1.1B Union 11/02/15 Boston
At Long Last, SEC Provides Final Equity Crowdfunding Rules 10/30/15 National
Despite Sanofi’s Help, MyoKardia Prices IPO Below Expectations 10/29/15 San Francisco
Vertex, CRISPR Tx Team up on Gene Editing Drugs in $105M Pact 10/26/15 Boston
Texas Roundup: Solar Winds, VMware, Procyrion, Houston Tech Center 10/26/15 Texas
West Coast Bio Roundup: Theranos, 23andMe, Invitae, Gritstone, Etc. 10/23/15 San Francisco
Page 2 of 20 « previous page · next page »